SCHEMBL19583308

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3614010	0.77	AGPAT2 (0.40)	MCL1ELANE
	SCHEMBL3611201	0.63	XDH (0.52)	—
	SCHEMBL9076045	0.62	ALDH1A1 (0.42)	RARARARBRARGELANE
	SCHEMBL2335195	0.61	XDH (0.50)	FAAH
	SCHEMBL22235038	0.61	GSK3B (0.32)	—
	Potassium Ion SCHEMBL25306840	0.60	XDH (0.35)	FAAHELANE
	SCHEMBL21474634	0.60	RARA (0.46)	RARARARBRARG
	SCHEMBL3817775	0.59	AGPAT2 (0.41)	MCL1ELANE
	SCHEMBL21682415	0.58	DPP4 (0.34)	—
	Lithium Ion SCHEMBL31728429	0.57	GSK3B (0.32)	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.